Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere

Browsing by Author Abdelkader, W

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Showing results 1 to 34 of 34
Publication DateTitleAuthor(s)
Apr-2021COVID-19 living evidence synthesis #6 (version 6.2): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Sep-2021COVID-19 living evidence synthesis #6 (version 6.20): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Oct-2021COVID-19 living evidence synthesis #6 (version 6.21): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Oct-2021COVID-19 living evidence synthesis #6 (version 6.22): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Nov-2021COVID-19 living evidence synthesis #6 (version 6.23): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Nov-2021COVID-19 living evidence synthesis #6 (version 6.24): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Dec-2021COVID-19 living evidence synthesis #6 (version 6.25): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Dec-2021COVID-19 living evidence synthesis #6 (version 6.26): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Jan-2022COVID-19 living evidence synthesis #6 (version 6.27): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Jan-2022COVID-19 living evidence synthesis #6 (version 6.28): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Feb-2022COVID-19 living evidence synthesis #6 (version 6.29): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Apr-2021COVID-19 living evidence synthesis #6 (version 6.3): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Feb-2022COVID-19 living evidence synthesis #6 (version 6.30): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Mar-2022COVID-19 living evidence synthesis #6 (version 6.33): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Apr-2022COVID-19 living evidence synthesis #6 (version 6.34): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Apr-2022COVID-19 living evidence synthesis #6 (version 6.35): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
May-2022COVID-19 living evidence synthesis #6 (version 6.36): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
May-2022COVID-19 living evidence synthesis #6 (version 6.37): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Jun-2022COVID-19 living evidence synthesis #6 (version 6.38): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Jul-2022COVID-19 living evidence synthesis #6 (version 6.39): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Aug-2022COVID-19 living evidence synthesis #6 (version 6.40): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Sep-2022COVID-19 living evidence synthesis #6 (version 6.41): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN
Dec-2021COVID-19 living evidence synthesis #8 (version 1): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, J; Patiño-Lugo, DF
May-2022COVID-19 living evidence synthesis #8 (version 11): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, J; Patiño-Lugo, DF
May-2022COVID-19 living evidence synthesis #8 (version 12): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Jun-2022COVID-19 living evidence synthesis #8 (version 13): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Jun-2022COVID-19 living evidence synthesis #8 (version 14): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Aug-2022COVID-19 living evidence synthesis #8 (version 15): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Sep-2022COVID-19 living evidence synthesis #8 (version 16): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Oct-2022COVID-19 living evidence synthesis #8 (version 17): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Nov-2022COVID-19 living evidence synthesis #8 (version 18): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Dec-2022COVID-19 living evidence synthesis #8 (version 19): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Jan-2022COVID-19 living evidence synthesis #8 (version 2): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Feb-2023COVID-19 living evidence synthesis #8 (version 21): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern?Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF
Showing results 1 to 34 of 34
Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue